---
layout: post
title: Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK
  Stock Down 1%
canonical_url: https://www.coinspeaker.com/merck-q1-2023-report-sales/
tag: CoinSpeaker
---

<p><a rel="nofollow" href="https://www.coinspeaker.com">Coinspeaker</a><br />
<a rel="nofollow" href="https://www.coinspeaker.com/merck-q1-2023-report-sales/">Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK Stock Down 1%</a></p>
<p>Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report.</p>
<p><a rel="nofollow" href="https://www.coinspeaker.com/merck-q1-2023-report-sales/">Merck Q1 2023 Report Shows Revenue Drop as COVID Treatment Sales Crash, MRK Stock Down 1%</a></p>
